Graham Burnett-Hall, Shoosmiths

Overview:

Solicitor advocate Graham Burnett-Hall is well-known for his multi-jurisdictional work in all areas of technology, particularly in pharmaceutical and biotechnology patent disputes. Burnett-Hall joined Shoosmiths in spring of 2024 from Marks & Clerk where he had been a partner for 20 years.

He studied chemistry before training as a lawyer and is a member of the Royal Society of Chemistry. Burnett-Hall’s scientific background is considered an asset to his clients and their research and development teams, both in and outside the courts.

He has been involved in notable cases in the Patents Court such as a multinational patent dispute concerning RSV vaccines based on the RSV perfusion F-protein. A peer who has worked with Burnett-Hall on national litigation comments: “He has a very good technical understanding and is a good strategist. I definitely can recommend working with him.”




More on this story

Trademarks
11 November 2025   How do you balance decisive trademark enforcement with the risk of public backlash? Counsel from Oracle, Uber and Meta explore why sometimes restraint can be the most strategic move. Muireann Bolger reports.
Trademarks
10 November 2025   The company behind the popular insulated tumblers has filed a lawsuit in California to protect the cup that reportedly increased its revenue tenfold in four years.
Careers
10 November 2025   Firm expands Pacific Northwest offering with new partner who brings “versatility across IP, securities, and commercial disputes”.

More on this story

Trademarks
11 November 2025   How do you balance decisive trademark enforcement with the risk of public backlash? Counsel from Oracle, Uber and Meta explore why sometimes restraint can be the most strategic move. Muireann Bolger reports.
Trademarks
10 November 2025   The company behind the popular insulated tumblers has filed a lawsuit in California to protect the cup that reportedly increased its revenue tenfold in four years.
Careers
10 November 2025   Firm expands Pacific Northwest offering with new partner who brings “versatility across IP, securities, and commercial disputes”.